Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oramed Pharmaceuticals (ORMP) Times Interest Earned (2023 - 2024)

Oramed Pharmaceuticals (ORMP) has disclosed Times Interest Earned for 2 consecutive years, with -$12.01 as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Times Interest Earned changed N/A year-over-year to -$12.01, compared with a TTM value of -$14.98 through Dec 2024, down 93.55%, and an annual FY2024 reading of -$14.98, down 93.55% over the prior year.
  • Times Interest Earned was -$12.01 for Q2 2024 at Oramed Pharmaceuticals, down from -$5.0 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$3.2 in Q4 2023 and bottomed at -$12.01 in Q2 2024.